D. Boral Capital
Upgrade grade
A+
Downgrade grade
C
D. Boral Capital is an investment bank and equity research firm that has established itself as a notable participant in the US equities markets with approximately 863 analyst ratings calls tracked in major databases. The firm brings a focused approach to equity research and advisory services, positioning itself within the competitive landscape of mid-market investment banking operations. D. Boral Capital has developed particular expertise in covering select sectors of the US market, building credibility through sustained coverage and analytical depth across multiple industry verticals. What distinguishes the firm within research circles is its commitment to maintaining independence in its analytical viewpoints, earning recognition among institutional clients who value contrarian perspectives and thorough fundamental research that challenges market consensus.
Upgrades
6
100.0% win rate
· avg +9.14% D1
Downgrades
22
77.27% win rate
· avg -12.99% D1
Avg Gap — Upgrades
+6.44%
open vs prev close
Avg Gap — Downgrades
-6.35%
open vs prev close
Performance by Sector
| Sector | ↑ Win% | ↑ D1 | ↓ Win% | ↓ D1 |
|---|---|---|---|---|
| Healthcare | — | — | 76.19% (21) | -12.22% |
Win Rate by Year
| Year | ↑ Win% | ↑ Calls | ↓ Win% | ↓ Calls |
|---|---|---|---|---|
| 2026 | — | — | 80.0% | 10 |
| 2025 | — | — | 70.0% | 10 |
Recent Calls
| Date | Ticker | Company | Sector | Action | Grade Change | PT | Gap | D1 |
|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | CANF | Can-Fite BioPharma Ltd. | Healthcare | Upgrade | Hold → Buy | $7 | +1.5% | +7.4% |
| May 4, 2026 | PRLD | Prelude Therapeutics Incorporated | Healthcare | Initiates | Buy | $9 | +2.6% | +0.9% |
| Apr 30, 2026 | LUNG | Pulmonx Corporation | Healthcare | Maintains | Buy → Buy | — | -1.7% | +6.7% |
| Apr 30, 2026 | OSTX | OS Therapies Incorporated | Healthcare | Maintains | Buy → Buy | — | +6.1% | +4.3% |
| Apr 28, 2026 | BMEA | Biomea Fusion, Inc. | Healthcare | Maintains | Buy → Buy | — | -0.6% | -11.6% |
| Apr 28, 2026 | HUMA | Humacyte, Inc. | Healthcare | Maintains | Buy → Buy | — | +2.4% | +5.2% |
| Apr 27, 2026 | CMPX | Compass Therapeutics, Inc. | Healthcare | Maintains | Buy → Buy | — | -64.8% | -64.4% |
| Apr 27, 2026 | CRMD | CorMedix Inc. | Healthcare | Maintains | Buy → Buy | — | +1.5% | +5.4% |
| Apr 24, 2026 | HUMA | Humacyte, Inc. | Healthcare | Maintains | Buy → Buy | — | +0.0% | -1.1% |
| Apr 23, 2026 | NRXP | NRx Pharmaceuticals, Inc. | Healthcare | Maintains | Buy → Buy | — | -0.3% | -4.4% |
| Apr 22, 2026 | CRVO | CervoMed Inc. | Healthcare | Maintains | Buy → Buy | — | +2.8% | +1.3% |
| Apr 21, 2026 | HUMA | Humacyte, Inc. | Healthcare | Maintains | Buy → Buy | — | -0.3% | -4.1% |
| Apr 21, 2026 | OMER | Omeros Corporation | Healthcare | Maintains | Buy → Buy | — | -0.5% | -1.6% |
| Apr 21, 2026 | IBRX | ImmunityBio, Inc. | Healthcare | Maintains | Buy → Buy | — | +2.1% | -1.2% |
| Apr 20, 2026 | MDCX | Medicus Pharma Ltd. Common Stock | Healthcare | Maintains | Buy → Buy | — | -3.3% | -2.1% |
| Apr 20, 2026 | VNRX | VolitionRx Limited | Healthcare | Downgrade | Buy → Hold | — | -5.3% | -8.9% |
| Apr 20, 2026 | NRXP | NRx Pharmaceuticals, Inc. | Healthcare | Maintains | Buy → Buy | — | +0.0% | +25.5% |
| Apr 20, 2026 | NNOX | Nano-X Imaging Ltd. | Healthcare | Maintains | Buy → Buy | — | -16.8% | -24.6% |
| Apr 17, 2026 | TRVI | Trevi Therapeutics, Inc. | Healthcare | Maintains | Buy → Buy | — | -0.8% | +4.7% |
| Apr 16, 2026 | GOVX | GeoVax Labs, Inc. | Healthcare | Maintains | Hold → Hold | — | -1.6% | -3.9% |
| Apr 16, 2026 | EVTL | Vertical Aerospace Ltd. | Industrials | Maintains | Buy → Buy | — | +13.2% | +25.6% |
| Apr 15, 2026 | IMUX | Immunic, Inc. | Healthcare | Downgrade | Buy → Hold | — | -8.5% | -5.9% |
| Apr 15, 2026 | VERI | Veritone, Inc. | Technology | Maintains | Buy → Buy | — | +0.0% | -8.3% |
| Apr 14, 2026 | HOVR | New Horizon Aircraft Ltd. | Industrials | Maintains | Buy → Buy | — | -0.6% | +0.0% |
| Apr 13, 2026 | NNOX | Nano-X Imaging Ltd. | Healthcare | Maintains | Buy → Buy | — | +0.9% | +4.8% |